FFA
IMCR icon

Farther Finance Advisors’s Immunocore IMCR Stock Holding History

Farther Finance Advisors’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.91K Sell
61
-46
-43% -$1.36K ﹤0.01% 5184
2026
Q1 		$3.24K Sell
107
-124
-54% -$4.01K ﹤0.01% 4701
2025
Q4 		$8.02K Buy
231
+154
+200% +$5.44K ﹤0.01% 4055
2025
Q3 		$2.8K Buy
+77
New +$2.62K ﹤0.01% 4005
2024
Q3 		– Sell
-99
Closed -$3.61K – 4064
2024
Q2 		$3.61K Buy
+99
New +$5.05K ﹤0.01% 2540

Other funds holding IMCR

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
TC
Trust Company Manhattan, Kansas $1.11B AUM 13.1% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Farther Finance Advisors's IMCR Position: Q2 2026 in Review

Farther Finance Advisors reduced its Immunocore (IMCR) stake by 43% in Q2 2026, selling an estimated $1.36K and leaving 61 shares worth $1.91K. The position accounts for ﹤0.01% of the portfolio, ranked #5184.

Farther Finance Advisors first reported a position in IMCR in Q2 2024 and has held it in 5 quarters since. The position peaked at $8.02K in Q4 2025. 14 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Farther Finance Advisors held 61 shares of Immunocore worth $1.91K as of Q2 2026.
  • Farther Finance Advisors sold 46 Immunocore shares in Q2 2026, an estimated $1.36K.
  • Immunocore made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5184 holding.
  • Farther Finance Advisors first reported a position in Immunocore in Q2 2024 and has held it in 5 quarters since.
  • Farther Finance Advisors's Immunocore position peaked at $8.02K in Q4 2025.
  • 14 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.